You are here: Industry Insights > Breast Cancer

News List

450,000 missed breast cancer screenings, 270 lives potentially shortened pharmafile
May 03, 2018
An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s Health Secretary, said that 270 women may have had their lives shortened as a result.
Researchers discover ‘new line of attack’ on triple negative breast cancer pharmatimes
March 14, 2018
Scientists have uncovered a novel approach to fighting hard-to-treat breast cancers, triggering a new drug programme designed to develop novel targeted therapies for the disease.
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the B biospace
March 07, 2018
The U.S. Food and Drug Administration today authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected Variants)
Kisqali receives FDA Breakthrough Therapy for advanced breast cancer europeanpharmaceuticalreview
January 04, 2018
Kisqali receives FDA Breakthrough Therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer…
CYC065-eribulin combination for triple-negative breast cancer identified europeanpharmaceuticalreview
September 28, 2017
Researchers find novel combination disrupts multiple factors in aggressive breast cancer…
Puma gains as Roche breast cancer combo disappoints pharmaphorum
June 07, 2017
Few would have predicted that little biotech Puma would get the advantage over mighty Roche in the race to develop a new breast cancer drug.
Lilly reports positive data for breast cancer drug pharmatimes
April 26, 2017
Eli Lilly is gearing up to file data for its experimental breast cancer drug abemaciclib after it was found to slow disease progression in a late-stage trial.